Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;33(8):1848.e15-20.
doi: 10.1016/j.neurobiolaging.2012.02.011. Epub 2012 Mar 13.

C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population

Collaborators, Affiliations

C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population

Mario Sabatelli et al. Neurobiol Aging. 2012 Aug.

Abstract

It has been recently reported that a large proportion of patients with familial amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are associated with a hexanucleotide (GGGGCC) repeat expansion in the first intron of C9ORF72. We have assessed 1757 Italian sporadic ALS cases, 133 from Sardinia, 101 from Sicily, and 1523 from mainland Italy. Sixty (3.7%) of 1624 mainland Italians and Sicilians and 9 (6.8%) of the 133 Sardinian sporadic ALS cases carried the pathogenic repeat expansion. None of the 619 regionally matched control samples (1238 chromosomes) carried the expansion. Twenty-five cases (36.2%) had behavioral FTD in addition to ALS. FTD or unspecified dementia was also detected in 19 pedigrees (27.5%) in first-degree relatives of ALS patients. Cases carrying the C9ORF72 hexanucleotide expansion survived 1 year less than cases who did not carry this mutation. In conclusion, we found that C9ORF72 hexanucleotide repeat expansions represents a sizeable proportion of apparent sporadic ALS in the Italian and Sardinian population, representing by far the most common mutation in Italy and the second most common in Sardinia.

PubMed Disclaimer

Conflict of interest statement

Disclosure statement

The authors disclose no conflicts. Appropriate Ethical Committee approvals were in place for this work.

Figures

Figure 1
Figure 1
Cumulative probability of disease onset according to the age of patients. Comparison between sporadic ALS patients with, hexanucleotide repeat expansion of the C9ORF72 gene or unknown genetic mutation (p=0.003).
Figure 2
Figure 2
Cumulative survival probability from time of disease onset. Comparison between sporadic ALS patients with hexanucleotide repeat expansion of the C9ORF72 gene and patients without known genetic mutation (p=0.023). Blue, unknown mutation; green, C9ORF72. Marks are censored patients.

References

    1. Brooks BR, Miller RG, Swash M, Munsat TL World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–299. - PubMed
    1. Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, Hardiman O. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12 157–5. - PubMed
    1. Chiò A, Borghero G, Pugliatti M, Ticca A, Calvo A, Moglia C, Mutani R, Brunetti M, Ossola I, Marrosu MG, Murru MR, Floris G, Cannas A, Parish LD, Cossu P, Abramzon Y, Johnson JO, Nalls NA, Arepalli S, Chong S, Hernandez DG, ITALSGEN, Consortium. Traynor BJ, Restagno G. A large proportion of ALS cases in Sardinia are due to a single founder mutation of the TARDBP gene. Arch. Neurol. 2011;68:594–598. - PMC - PubMed
    1. Chiò A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, Sendtner M, Brunetti M, Ossola I, Calvo A, Pugliatti M, Sotgiu MA, Murru MR, Marrosu MG, Marrosu F, Marinou K, Mandrioli J, Sola P, Caponnetto C, Mancardi G, Mandich P, La Bella V, Spataro R, Conte A, Monsurrò MR, Tedeschi G, Pisano F, Bartolomei I, Salvi F, Lauria Pinter G, Simone I, Logroscino G, Gambardella A, Quattrone A, Lunetta C, Volanti P, Zollino M, Penco S, Battistini S, the ITALSGEN consortium. Renton AE, Majounie E, Abramzon Y, Conforti FL, Giannini F, Corbo M, Sabatelli M. Clinical characteristics of familial ALS patients carrying the pathogenic GGGGCC hexanucleotide repeat expansion of the C9ORF72 gene. Brain. in press. - PMC - PubMed
    1. Chiò A, Traynor BJ, Lombardo F, Fimognari M, Calvo A, Ghiglione P, Mutani R, Restagno G. Prevalence of SOD1 mutations in the Italian ALS population. Neurology. 2008;70:533–537. - PubMed

Publication types